Skip to main content
Premium Trial:

Request an Annual Quote

Two of Gene Logic s Japanese Customers Renew Subscriptions

NEW YORK, June 7 (GenomeWeb News) - Two Japanese customers of GeneLogic have renewed their subscriptions to its BioExpress database, the company said today.


The companies - Takeda Pharmaceutical and Daiichi Pharmaceutical - have been subscribers for the last three years. Takeda is now signed on until the end of 2006 and purchased a perpetual license to the data content as of the expiration date of the latest agreement. Daiichi signed up for several more years and will use the system primarily for drug discovery research, with an option to expand to other areas.


Financial terms of the agreements were not disclosed.


Gene Logic's BioExpress consists of genomic and clinical information from a range of normal and pathological human tissues, as well as animal model system tissues and cell lines.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.